Related Experiment Video
Updated: Aug 2, 2026

Monitoring Cell-autonomous Circadian Clock Rhythms of Gene Expression Using Luciferase Bioluminescence Reporters
Published on: September 27, 2012
Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2
John A Schoenhard1, Layton H Smith, Corrie A Painter
1Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, 383 PRB, Nashville, TN 37232, USA.
Insights
Circadian clock proteins CLOCK:BMAL1 and CLOCK:BMAL2 regulate plasminogen activator inhibitor-1 (PAI-1) gene transcription. This regulation influences the timing of heart attacks and thrombolytic therapy effectiveness.
Area of Science:
- Molecular Biology
- Chronobiology
- Cardiovascular Research
Background:
- Circadian variation in plasminogen activator inhibitor-1 (PAI-1) is linked to morning myocardial infarction risk and reduced thrombolytic therapy efficacy.
- Understanding the molecular mechanisms regulating PAI-1 circadian rhythm is crucial for cardiovascular health.
Purpose of the Study:
- To investigate how core circadian clock components regulate the human PAI-1 promoter in endothelial cells.
- To determine the role of CLOCK:BMAL1 and CLOCK:BMAL2 heterodimers in PAI-1 gene transcription.
Main Methods:
- Transfection of endothelial cells with human PAI-1 promoter constructs.
- Analysis of promoter activity regulated by CLOCK:BMAL1 and CLOCK:BMAL2 heterodimers.
- Investigation of the influence of the PAI-1 4G/5G polymorphism on promoter activity.
Main Results:
- Both CLOCK:BMAL1 and CLOCK:BMAL2 heterodimers activate the PAI-1 promoter via proximal and distal E-box enhancers.
- The 4G/5G polymorphism at the distal E-box does not affect transactivation by CLOCK:BMAL1 or CLOCK:BMAL2.
- CLOCK:BMAL1 and CLOCK:BMAL2 contribute additively to PAI-1 gene transcription, with differential activation but equivalent inhibition susceptibility.
Conclusions:
- Core circadian clock components CLOCK:BMAL1 and CLOCK:BMAL2 are key regulators of human PAI-1 transcription.
- These molecular interactions provide a basis for circadian variation in PAI-1 and its impact on atherothrombotic events.
- Understanding these mechanisms may inform strategies for managing cardiovascular events and optimizing thrombolytic therapy.
Abstract:
Circadian variation in plasminogen activator inhibitor-1 (PAI-1) production likely contributes to increased risk of myocardial infarction and decreased efficacy of thrombolytic therapy during the morning. In this study, we characterize the abilities of fundamental molecular components of intrinsic circadian clocks to regulate the human PAI-1 promoter in transfected endothelial cells. Both CLOCK:BMAL1 and CLOCK:BMAL2 heterodimers activate the PAI-1 promoter through requisite proximal (-565 to -560 bp) and distal (-680 to -675 bp) E-box enhancers. Although the distal E-box overlaps the 4G/5G polymorphism of the PAI-1 promoter, allelic variation at this site does not influence CLOCK:BMAL1-and CLOCK:BMAL2-mediated transactivation. Together, CLOCK:BMAL1 and CLOCK:BMAL2 make additive contributions to PAI-1 gene transcription. While the abilities of these heterodimers to activate gene expression differ by twofold, the susceptibilities of these circadian activators to inhibition by period and cryptochrome proteins are equivalent and redox independent. Given that BMAL1 and BMAL2 differ in their spatiotemporal distributions, such distinctions may allow intrinsic circadian clocks to modulate the amplitudes of their oscillators, while maintaining circadian periodicity. In this way, fundamental circadian clock components may drive circadian variation in PAI-1, which in turn influences the pathogenesis, timing, and treatment of acute atherothrombotic events.
Related Concept Videos
Biological Clocks and Seasonal Responses
Cell Specific Gene Expression
Master Transcription Regulators
Circadian Rhythms and Gene Regulation
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...

